Aurobindo Pharma
AUROPHARMA.NS
HK$99.57
Share price
1.36%
Change (1 day)
-12.93%
Change (1 year)
Categories
Market capitalization of Aurobindo Pharma (AUROPHARMA.NS)
Market cap: HK$57.83 Billion
As of June 2025 Aurobindo Pharma has a market cap of HK$57.83 Billion. This makes Aurobindo Pharma the world's 2230th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Aurobindo Pharma from 2005 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | HK$57.83 B | -13.76% |
| 2024 | HK$67.05 B | 12.43% |
| 2023 | HK$59.64 B | 145.94% |
| 2022 | HK$24.25 B | -46.2% |
| 2021 | HK$45.07 B | -21.22% |
| 2020 | HK$57.22 B | 95.73% |
| 2019 | HK$29.23 B | -39.21% |
| 2018 | HK$48.09 B | -2.16% |
| 2017 | HK$49.15 B | 9.95% |
| 2016 | HK$44.70 B | -25.06% |
| 2015 | HK$59.65 B | 47.27% |
| 2014 | HK$40.51 B | 182.15% |
| 2013 | HK$14.35 B | 83.93% |
| 2012 | HK$7.80 B | 114.87% |
| 2011 | HK$3.63 B | -71.43% |
| 2010 | HK$12.71 B | 55.22% |
| 2009 | HK$8.19 B | 462.81% |
| 2008 | HK$1.45 B | -74.71% |
| 2007 | HK$5.75 B | -13.35% |
| 2006 | HK$6.64 B | 84.76% |
| 2005 | HK$3.59 B |